Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Canna-Tsu
- Development stage
- Unknown
- Lead developer
- Southern Humboldt Seed Collective
- Modality
- Small Molecules
- Administration
- Inhalation, Oral, Topical
01
Overview
Canna-Tsu is a high-cannabidiol (CBD) cannabis strain developed by the Southern Humboldt Seed Collective, resulting from a cross between Cannatonic and Sour Tsunami. It is characterized by a high CBD-to-THC ratio, typically ranging from 1:1 to 5:1, which provides therapeutic benefits with minimal psychoactive effects. The primary active components, CBD and THC, interact with the endocannabinoid system, specifically targeting CB1 and CB2 receptors. CBD acts as a non-competitive negative allosteric modulator of CB1 receptors and an agonist at 5-HT1A receptors, contributing to its analgesic, anti-inflammatory, and anxiolytic properties. It is frequently utilized in the management of chronic pain, inflammation, epilepsy, and anxiety disorders.
- Brand names
- Canna-Tsu
- Other names
- CannaTsu
02
Targets
CNR2 (Cannabinoid receptor type 2)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on Canna-Tsu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Canna-Tsu.